Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 2,000.00$ 6,900.00

Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market: By Product Type (Valves, Delivery System), By End Users (Hospitals, Cardiology Clinics, Ambulatory Surgical Centers) and Geography

 

$ PRICE - $ 2,000.00$ 6,900.00
Region Middle East and Africa
Clear selection
Clear
$ PRICE - $ 2,000.00$ 6,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market size was estimated at USD Bn in 2021, growing at a CAGR of % during the forecast period 2022-2028.. Transcatheter pulmonary valve replacement is a surgical procedure carried in older children and adults with congenital heart disease and have normally at least one previous operation. These valves are delivery by hollow, thin, and long tube system that delivers the transcatheter pulmonary valve into hear without open heart surgery. Increase in the prevalence of congenital heart diseases, expansion of business by the companies in Middle east region, economic growth, and prolonged efficiency of transcatheter pulmonary valves are anticipated to propel the Middle East and Africa transcatheter pulmonary valve (TPV) therapy market over the forecast years. However, stringent regulations for product approval, lack of awareness in underdeveloped countries, and high cost of therapy may hamper the growth of the market.


Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market

MARKET SUMMARY
-
% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– %
  • Largest Market– GCC Countries

Middle East and Africa

Transcatheter Pulmonary Valve (TPV) Therapy Market

  • Middle East and Africa transcatheter pulmonary valve (TPV) therapy market is segmented on the basis of product type, end user, and country.
  • Geographically, Middle East and Africa transcatheter pulmonary valve (TPV) therapy market is segmented into Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa.
Market Key Players
  • Venus MedTech (China)
  • Inova (U.S.)
  • Edward Lifesciences (U.S.)
  • Medtronic Plc. (Ireland)
Drivers And Restraints

Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market

Increase in the prevalence of congenital heart diseases is a key factor drive the growth of transcatheter pulmonary valve therapy market. Moreover, prolonged effectiveness of transcatheter valves, increase in the R&D for the innovation of newer products, and change in lifestyle leads to increase in prevalence of cardiovascular diseases are anticipated to fuel the transcatheter pulmonary valve (TPV) therapy market over the forecast period. However, stringent regulatory guidelines, low target population, high cost of therapy, and lack of skilled professionals may restrain the growth of transcatheter pulmonary valve (TPV) therapy market.


Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market

Geographically, Middle East and Africa transcatheter pulmonary valve (TPV) therapy market is segmented into Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa. Gulf Cooperation Council (GCC) Countries transcatheter pulmonary valve therapy market is growing at significant rate due to entry of companies into Middle East region, increase in healthcare expenditure, and rise in adoption of newer devices are anticipated to fuel the market. South Africa transcatheter pulmonary valve therapy market has a significant share due increase in awareness about transcatheter valves efficiency, rising healthcare expenditure, and rise in prevalence of congenital heart disease are bolster the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, and forecast
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and start-up’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Segmentation

Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Venus MedTech (China)
  • Inova (U.S.)
  • Edward Lifesciences (U.S.)
  • Medtronic Plc. (Ireland)

Description

Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market size was estimated at USD Bn in 2021, growing at a CAGR of % during the forecast period 2022-2028.. Transcatheter pulmonary valve replacement is a surgical procedure carried in older children and adults with congenital heart disease and have normally at least one previous operation. These valves are delivery by hollow, thin, and long tube system that delivers the transcatheter pulmonary valve into hear without open heart surgery. Increase in the prevalence of congenital heart diseases, expansion of business by the companies in Middle east region, economic growth, and prolonged efficiency of transcatheter pulmonary valves are anticipated to propel the Middle East and Africa transcatheter pulmonary valve (TPV) therapy market over the forecast years. However, stringent regulations for product approval, lack of awareness in underdeveloped countries, and high cost of therapy may hamper the growth of the market.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX